{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:28:54Z","timestamp":1788776934044,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jemermed.2014.12.024","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T02:51:04Z","timestamp":1428288664000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["American Academy of Emergency Medicine Position Statement: Safety of Droperidol Use in the Emergency Department"],"prefix":"10.1016","volume":"49","author":[{"given":"Jack","family":"Perkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Vilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"DeMers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2014.12.024_bib1","first-page":"1167","article-title":"Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam","volume":"12","author":"Martel","year":"2008","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/bja\/83.5.813","article-title":"Ondansetron and droperidol in the prevention of postoperative nausea and vomiting","volume":"83","author":"Bugedo","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jemermed.2014.12.024_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1197\/aemj.9.6.650","article-title":"Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial","volume":"9","author":"Irving","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jemermed.2010.07.005","article-title":"Droperidol analgesia for opioid-tolerant patients","volume":"41","author":"Richards","year":"2011","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1553-2712.2001.tb01147.x","article-title":"Droperidol vs. procholorperazine for benign headaches in the emergency department","volume":"8","author":"Miner","year":"2001","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib6","first-page":"1402","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","author":"Chase","year":"2008","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib7","unstructured":"U.S. Food and Drug Administration. FDA strengthens warnings for droperidol. FDA Talk Paper. Available at: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm173778.htm. Accessed January 10,\u00a02014."},{"key":"10.1016\/j.jemermed.2014.12.024_bib8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2146\/ajhp060505","article-title":"Evidence-based review of the black-box warning for droperidol","volume":"64","author":"Jackson","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jemermed.2014.12.024_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mem.2003.110","article-title":"Droperidol, QT prolongation, and sudden death: what is the evidence?","volume":"41","author":"Kao","year":"2003","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib10","first-page":"3","article-title":"The effects of the FDA warning on the use of droperidol by U.S. emergency physicians","volume":"4","author":"Richards","year":"2003","journal-title":"Cal J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","article-title":"Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Silberstein","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2014.12.024_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/070674370104600922","article-title":"Evaluation of droperidol in the acutely agitated child or adolescent","volume":"46","author":"Hameer","year":"2001","journal-title":"Can J Psychiatary"},{"key":"10.1016\/j.jemermed.2014.12.024_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajem.2003.09.003","article-title":"Unexpected cardiovascular deaths are rare with therapeutic doses of droperidol","volume":"22","author":"Mullins","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized controlled trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jemermed.2003.05.005","article-title":"Droperidol vs. prochlorperazine for the treatment of acute headache","volume":"26","author":"Weaver","year":"2004","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ajem.2011.08.010","article-title":"Treating primary headaches in the ED: can droperidol regain its role?","volume":"30","author":"Faine","year":"2012","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/ajem.2002.30007","article-title":"A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache","volume":"20","author":"Richman","year":"2002","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","article-title":"Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol","volume":"16","author":"Richards","year":"1998","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajem.2013.03.026","article-title":"Parenteral sedation of elderly patients with acute behavioral disturbance in the ED","volume":"31","author":"Calver","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/ALN.0b013e31827dde8d","article-title":"Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?","volume":"118","author":"Nuttall","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jemermed.2014.12.024_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bcp.12272","article-title":"High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings","volume":"77","author":"Calver","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2014.12.024_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajem.2005.08.017","article-title":"Antiemetics in the ED: a randomized controlled trial comparing 3 common agents","volume":"24","author":"Braude","year":"2006","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1553-2712.2008.00197.x","article-title":"Olanzapine versus droperidol for the treatment of primary headache in the emergency department","volume":"15","author":"Hill","year":"2008","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PEC.0b013e3181d6d9f2","article-title":"Droperidol use in pediatric emergency department patients","volume":"26","author":"Szwak","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jemermed.2014.12.024_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1526-4610.1997.3706377.x","article-title":"Droperidol treatment of status migrainosus and refractory migraine","volume":"37","author":"Wang","year":"1997","journal-title":"Headache"},{"key":"10.1016\/j.jemermed.2014.12.024_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2014.12.024_bib28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00000542-200506000-00007","article-title":"Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study","volume":"102","author":"White","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jemermed.2014.12.024_bib29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jemermed.2014.12.024_bib30","first-page":"1256","article-title":"Small-dose droperidol effectively reduces nausea in a general surgical adult patient population","volume":"91","author":"Kreisler","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jemermed.2014.12.024_bib31","first-page":"731","article-title":"A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures","volume":"86","author":"Fortney","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jemermed.2014.12.024_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.anes.0000281893.39781.64","article-title":"Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?","volume":"107","author":"Nuttall","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jemermed.2014.12.024_bib33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.gie.2006.01.052","article-title":"Droperidol, when used for sedation during ERCP, may prolong the QT interval","volume":"63","author":"Yimcharoen","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jemermed.2014.12.024_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/10903120802706096","article-title":"Torsade de pointes after administration of droperidol for nausea and vomiting","volume":"13","author":"Choo","year":"2009","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jemermed.2014.12.024_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00540-007-0550-x","article-title":"The use of droperidol decreases postoperative nausea and vomiting after gynecological laparoscopy","volume":"21","author":"Mitsunari","year":"2007","journal-title":"J Anesth"},{"key":"10.1016\/j.jemermed.2014.12.024_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000320747","article-title":"A randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting","volume":"71","author":"Ekinci","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jemermed.2014.12.024_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00004583-199802000-00017","article-title":"Use of droperidol in hospitalized children","volume":"37","author":"Joshi","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jemermed.2014.12.024_bib38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467914013468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467914013468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:33:06Z","timestamp":1760027586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467914013468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0736467914013468"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2014.12.024","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Academy of Emergency Medicine Position Statement: Safety of Droperidol Use in the Emergency Department","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2014.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}